Bioactivities from Marine Algae of the Genus Gracilaria
Author Information
Author(s): Cynthia Layse F. Falcão, Heloina de S. Lima, Gedson R. de M. Montenegro, Camila de A. Lira, Narlize S. de Athayde-Filho, Petrônio F. Rodrigues, Luis C. de Souza, Maria de Fátima V. Barbosa-Filho, José M. Batista, Leônia M.
Primary Institution: Federal University of Paraiba
Hypothesis
This study reviews the literature related to bioactivities for Gracilaria algae.
Conclusion
Gracilaria algae are a potential source for the synthesis of new natural medicines.
Supporting Evidence
- Gracilaria algae contain bioactive metabolites that can treat various diseases.
- Nineteen species of Gracilaria were tested for multiple biological activities.
- Algae represent about 9% of biomedical compounds obtained from the sea.
- Studies indicate that Gracilaria species have potential for drug development.
Takeaway
Seaweeds like Gracilaria can help make new medicines because they have special compounds that can fight diseases.
Methodology
The study reviewed literature published up to January 2011 regarding the bioactivities of Gracilaria algae.
Limitations
Most studies raised concerns about antimicrobial activity and the need for more comprehensive chemical profiles.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website